Tarsus Pharmaceuticals GAAP EPS of -$0.60 beats by $0.07, revenue of $66.41M beats by $7.61M

Read more

Related Posts

Zefiro Methane Corp. Announces Enhanced Orphaned Oil & Gas Well Capabilities via Partnerships Implementing AI & Blockchain-Backed Technologies

Sezzle Reports Fourth Quarter and Fiscal Year 2024 Results

The Inner Circle acknowledges, Gerald A. Groves, Jr., MD, Dr. PH as a Pinnacle Lifetime Member

Kessler Topaz Meltzer & Check, LLP Notifies Grocery Outlet Holding Corp. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit

Clorox Declares Regular Quarterly Dividend of $1.22 Per Share

HBM Alpha Therapeutics Enters Strategic Collaboration and License Agreement to Advance Novel Endocrine Therapies

Comments